Primecap Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,440
Closed -$211K 329
2026
Q1
$211K Hold
2,440
﹤0.01% 318
2025
Q4
$234K Sell
2,440
-1,380
-36% -$134K ﹤0.01% 315
2025
Q3
$364K Sell
3,820
-445,170
-99% -$40.9M ﹤0.01% 317
2025
Q2
$39.1M Sell
448,990
-218,115
-33% -$18.5M 0.03% 206
2025
Q1
$59.9M Sell
667,105
-60,080
-8% -$5.38M 0.05% 170
2024
Q4
$58.1M Sell
727,185
-137,760
-16% -$11.9M 0.05% 172
2024
Q3
$77.9M Sell
864,945
-5,380
-0.6% -$453K 0.06% 157
2024
Q2
$68.5M Sell
870,325
-6,850
-0.8% -$562K 0.05% 166
2024
Q1
$76.4M Buy
877,175
+480
+0.1% +$41K 0.06% 159
2023
Q4
$72.2M Sell
876,695
-3,595
-0.4% -$274K 0.06% 160
2023
Q3
$69M Sell
880,290
-4,510
-0.5% -$378K 0.06% 154
2023
Q2
$78M Sell
884,800
-55,630
-6% -$4.79M 0.07% 154
2023
Q1
$75.8M Sell
940,430
-107,740
-10% -$8.78M 0.07% 153
2022
Q4
$81.5M Sell
1,048,170
-19,150
-2% -$1.55M 0.07% 150
2022
Q3
$86.2M Sell
1,067,320
-2,050
-0.2% -$184K 0.08% 147
2022
Q2
$96M Sell
1,069,370
-5,480
-0.5% -$555K 0.09% 141
2022
Q1
$119M Sell
1,074,850
-34,890
-3% -$3.69M 0.09% 146
2021
Q4
$115M Sell
1,109,740
-8,600
-0.8% -$996K 0.08% 151
2021
Q3
$140M Sell
1,118,340
-618,510
-36% -$80.1M 0.1% 137
2021
Q2
$216M Sell
1,736,850
-406,510
-19% -$51M 0.14% 114
2021
Q1
$253M Sell
2,143,360
-126,330
-6% -$14.8M 0.18% 102
2020
Q4
$266M Sell
2,269,690
-202,390
-8% -$22.3M 0.2% 100
2020
Q3
$257M Sell
2,472,080
-106,350
-4% -$10.7M 0.21% 93
2020
Q2
$236M Sell
2,578,430
-80,340
-3% -$7.7M 0.2% 98
2020
Q1
$240M Sell
2,658,770
-2,312,830
-47% -$246M 0.24% 84
2019
Q4
$564M Sell
4,971,600
-249,375
-5% -$27.4M 0.41% 60
2019
Q3
$567M Sell
5,220,975
-1,206,550
-19% -$126M 0.45% 58
2019
Q2
$626M Sell
6,427,525
-120,170
-2% -$11M 0.46% 60
2019
Q1
$596M Sell
6,547,695
-687,080
-9% -$61.5M 0.44% 66
2018
Q4
$658M Sell
7,234,775
-246,220
-3% -$23M 0.53% 55
2018
Q3
$736M Sell
7,480,995
-681,957
-8% -$63M 0.5% 58
2018
Q2
$699M Sell
8,162,952
-16,340
-0.2% -$1.36M 0.52% 60
2018
Q1
$656M Sell
8,179,292
-573,806
-7% -$47.3M 0.49% 60
2017
Q4
$707M Sell
8,753,098
-502,912
-5% -$40.3M 0.54% 55
2017
Q3
$720M Sell
9,256,010
-612,900
-6% -$50.9M 0.6% 49
2017
Q2
$876M Sell
9,868,910
-1,224,655
-11% -$103M 0.75% 38
2017
Q1
$894M Sell
11,093,565
-1,674,357
-13% -$131M 0.81% 38
2016
Q4
$909M Sell
12,767,922
-1,714,747
-12% -$135M 0.89% 36
2016
Q3
$1.25B Sell
14,482,669
-498,335
-3% -$43.4M 1.25% 21
2016
Q2
$1.3B Sell
14,981,004
-215,977
-1% -$17.5M 1.38% 16
2016
Q1
$1.14B Buy
15,196,981
+9,330
+0.1% +$703K 1.18% 22
2015
Q4
$1.17B Sell
15,187,651
-73,225
-0.5% -$5.51M 1.19% 17
2015
Q3
$1.02B Sell
15,260,876
-1,135,220
-7% -$83.6M 1.13% 21
2015
Q2
$1.21B Sell
16,396,096
-1,149,125
-7% -$87.8M 1.2% 18
2015
Q1
$1.37B Sell
17,545,221
-1,032,945
-6% -$78.3M 1.34% 15
2014
Q4
$1.34B Sell
18,578,166
-10,957,407
-37% -$761M 1.36% 16
2014
Q3
$1.83B Sell
29,535,573
-66,655
-0.2% -$4.24M 1.96% 13
2014
Q2
$1.89B Sell
29,602,228
-1,967,960
-6% -$120M 2.07% 12
2014
Q1
$1.94B Sell
31,570,188
-44,615
-0.1% -$2.6M 2.2% 11
2013
Q4
$1.81B Sell
31,614,803
-229,418
-0.7% -$13M 2.18% 11
2013
Q3
$1.7B Sell
31,844,221
-286,100
-0.9% -$15.4M 2.23% 11
2013
Q2
$1.65B Buy
+32,130,321
New +$1.59B 2.37% 11

Other funds holding MDT

Primecap Management's MDT Position: Q2 2026 in Review

Primecap Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,440 shares — an estimated $211K sold.

Primecap Management first reported a position in MDT in Q2 2013 and held it in 52 quarters. The position peaked at $1.94B in Q1 2014. 2,126 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Primecap Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Primecap Management sold 2,440 Medtronic shares in Q2 2026, an estimated $211K.
  • Primecap Management first reported a position in Medtronic in Q2 2013 and held it in 52 quarters.
  • Primecap Management's Medtronic position peaked at $1.94B in Q1 2014.
  • 2,126 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.